367 related articles for article (PubMed ID: 19666590)
1. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics.
Abu-Raddad LJ; Sabatelli L; Achterberg JT; Sugimoto JD; Longini IM; Dye C; Halloran ME
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13980-5. PubMed ID: 19666590
[TBL] [Abstract][Full Text] [Related]
2. Prospects for advancing tuberculosis control efforts through novel therapies.
Salomon JA; Lloyd-Smith JO; Getz WM; Resch S; Sánchez MS; Porco TC; Borgdorff MW
PLoS Med; 2006 Aug; 3(8):e273. PubMed ID: 16866578
[TBL] [Abstract][Full Text] [Related]
3. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
[TBL] [Abstract][Full Text] [Related]
4. Parameters that influence the prediction of epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosis.
Vani J; Maddur MS; Lacroix-Desmazes S; Kaveri SV; Bayry J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):E129; author reply E130. PubMed ID: 19858487
[No Abstract] [Full Text] [Related]
5. Tuberculosis: a new vision for the 21st century.
Small PM
Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. [Current approach to diagnostics, treatment and prevention of tuberculosis].
Vašáková M
Vnitr Lek; 2018; 63(11):815-820. PubMed ID: 29303284
[TBL] [Abstract][Full Text] [Related]
8. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
[TBL] [Abstract][Full Text] [Related]
9. [Reform of Japan's NTP and its technical perspectives].
Mori T
Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
[TBL] [Abstract][Full Text] [Related]
10. The cursed duet today: Tuberculosis and HIV-coinfection.
Tiberi S; Carvalho AC; Sulis G; Vaghela D; Rendon A; Mello FC; Rahman A; Matin N; Zumla A; Pontali E
Presse Med; 2017 Mar; 46(2 Pt 2):e23-e39. PubMed ID: 28256380
[TBL] [Abstract][Full Text] [Related]
11. Curving Tuberculosis: Current Trends and Future Needs.
Rojano B; Caminero JA; Hayek M
Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741506
[TBL] [Abstract][Full Text] [Related]
12. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
Kendall EA; Shrestha S; Cohen T; Nuermberger E; Dooley KE; Gonzalez-Angulo L; Churchyard GJ; Nahid P; Rich ML; Bansbach C; Forissier T; Lienhardt C; Dowdy DW
PLoS Med; 2017 Jan; 14(1):e1002202. PubMed ID: 28045934
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis control in crisis-causes and solutions.
Kaplan G
Prog Biophys Mol Biol; 2020 May; 152():6-9. PubMed ID: 31626823
[TBL] [Abstract][Full Text] [Related]
15. [Fight against tuberculosis in the world].
El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis elimination: where are we now?
Matteelli A; Rendon A; Tiberi S; Al-Abri S; Voniatis C; Carvalho ACC; Centis R; D'Ambrosio L; Visca D; Spanevello A; Battista Migliori G
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29898905
[TBL] [Abstract][Full Text] [Related]
17. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
Chae H; Shin SJ
J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.
Collin SM; Wurie F; Muzyamba MC; de Vries G; Lönnroth K; Migliori GB; Abubakar I; Anderson SR; Zenner D
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31142548
[TBL] [Abstract][Full Text] [Related]
19. Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine.
Fu H; Lewnard JA; Frost I; Laxminarayan R; Arinaminpathy N
Nat Commun; 2021 Jan; 12(1):424. PubMed ID: 33462224
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
